Hiroshi Iwata
Impact in
-
- Neuropeptides and Animal Physiology
Papers in
-
- Acute Myocardial Infarction Research 14
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Surgery 68
- Coronary Interventions and Diagnostics 20
- Lipoproteins and Cardiovascular Health 19
- Co-authors
- Ryozo NagaiElena AïkawaClaudia GoettschYasunobu HirataMasanori AikawaNorifumi TakedaKei MaruyamaTakeshi Iwatsubo
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Journal of Cardiology (5 papers)PLoS ONE (5 papers)Circulation (5 papers)European Heart Journal (4 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hiroshi Iwata
212 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 166
- Cellular and Molecular Neuroscience 406
- Cardiology and Cardiovascular Medicine 505
- Endocrinology, Diabetes and Metabolism 324
- Nephrology 137
- Physiology 499
Countries citing papers authored by Hiroshi Iwata
This map shows the geographic impact of Hiroshi Iwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Iwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Iwata more than expected).
Fields of papers citing papers by Hiroshi Iwata
This network shows the impact of papers produced by Hiroshi Iwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Iwata. The network helps show where Hiroshi Iwata may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Iwata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 28 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 5 | |
| 13 | Preliminary study on the effects of movement velocity training of the upper limbs on gait ability in older adults: a nonrandomized controlled trial | 2019 | 0 |
| 14 | 2019 | 1 | |
| 15 | 2019 | 13 | |
| 16 | 2018 | 10 | |
| 17 | Abstract 16180: K-877, A Novel PPAR-alpha Selective Agonist, Suppresses Macrophage Activation and Arterial Lesion Formation | 2013 | 5 |
| 18 | 2012 | 56 | |
| 19 | Vibration and Noise Reduction of Compressors for Air-Conditioner | 2011 | 1 |
| 20 | 2007 | 13 |
About Hiroshi Iwata
Hiroshi Iwata is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Physical Therapy, Sports Therapy and Rehabilitation, Microbiology and Biological Psychiatry, having authored 235 papers that have together received 3.9k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (20 papers), Lipoproteins and Cardiovascular Health (19 papers), Acute Myocardial Infarction Research (14 papers), Cardiac Imaging and Diagnostics (12 papers), Adipokines, Inflammation, and Metabolic Diseases (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Cancer, Lipids, and Metabolism (8 papers) and Semiconductor Quantum Structures and Devices (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (406 citations), Cardiology and Cardiovascular Medicine (505 citations), Endocrinology, Diabetes and Metabolism (324 citations), Nephrology (137 citations) and Physiology (499 citations). Hiroshi Iwata has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Ryozo Nagai, Elena Aïkawa, Claudia Goettsch, Yasunobu Hirata, Masanori Aikawa, Norifumi Takeda, Kei Maruyama, Takeshi Iwatsubo, Taisuke Tomita and Takayuki Shindo. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Cardiology, PLoS ONE, Circulation and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.